Concert Pharmaceuticals, Inc. to Ring The NASDAQ Stock

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Concert Pharmaceuticals, Inc. [CNCE] to Ring The NASDAQ Stock Market Opening Bell

ADVISORY, April 11, 2014 (GLOBE NEWSWIRE) --

What:

Concert Pharmaceuticals, Inc. [CNCE], a clinical stage biopharmaceutical company creating novel drugs for CNS disorders, renal disease, inflammation and cancer, will visit the NASDAQ MarketSite in Times Square.

In honor of the occasion, Dr. Roger Tung, Chief Executive Officer will ring the Opening Bell.

Where:

NASDAQ MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio

When:

Monday, April 14, 2014 – 9:15 a.m. to 9:30 a.m. ET        

Concert Pharmaceuticals, Inc. Contact:
Justine Koenigsberg
(781) 860-0045
jkoenigsberg@concertpharma.com

NASDAQ MarketSite:
Christine Barna
(646) 441-5310
Christine.Barna@nasdaqomx.com

Feed Information:
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ .

For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq

For news tweets, please visit our Twitter page at: http://twitter.com/nasdaqomx .

For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/

Webcast:

A webcast of the NASDAQ Opening Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Concert Pharmaceuticals, Inc. [CNCE]:

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel small molecule drugs. This approach starts with approved drugs, advanced clinical candidates or previously studied compounds that have the potential to be improved with deuterium substitution to enhance clinical safety, tolerability and efficacy. The company is developing a broad pipeline targeting CNS disorders, renal disease, inflammation and cancer.

About NASDAQ OMX Group

NASDAQ OMX (Nasdaq: NDAQ ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, NASDAQ OMX enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. NASDAQ OMX is home to more than 3,300 listed companies with a market value of over $8 trillion. To learn more, visit www.nasdaqomx.com .   

-NDAQA-

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 30

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

Palantir Technologies: Navigating Market Challenges Ahead

Updated Category News Views 241

Palantir Technologies: An Overview of Current Stock Trends Palantir Technologies (NASDAQ: PLTR) has recently experienced fluctuations in its stock prices, especially after being announced as a new member of the NASDAQ 100. In the days following this announcement, investors observed a pullback of more than 5%, which can be closely tied to broader market trends influenced...

Continue Reading
Flood Coverage: Gaps in Home Insurance to Watch

Updated Category News Views 15

Ask any homeowner in Westchester County about insurance, and you'll hear the same buzzword—flood. Sure, it's a tranquil spot to call home, but the insurance maze here can leave folks scratching their heads. When it rains cats and dogs, will your standard policy bail you out? Spoiler alert: Absolutely not. The Ins and Outs of Home Insurance Homeowners insurance isn't...

Continue Reading
Exploring the Impact of Food Apps on Brand Loyalty Dynamics

Updated Category News Views 186

The Influence of Food Ordering Apps on Brand Loyalty In our increasingly digital world, the way we connect with brands has transformed dramatically. One striking example of this is the rise of food ordering apps. It's common for many of us to bypass dining out in favor of the convenience offered by services like DoorDash and Uber Eats. In fact, recent studies highlight...

Continue Reading
The Trimer Acid Market: Growth, Trends, and Future Prospects

Updated Category News Views 113

Understanding the Growth of the Trimer Acid Industry The trimer acid industry has been on a remarkable growth journey as sectors globally pivot towards viable and sustainable materials. Known primarily for its role in the production of adhesives, sealants, coatings, and polyamide resins, trimer acid demonstrates versatility that appeals to various industries such as...

Continue Reading
Exploring Investment Strategies During Economic Uncertainty

Updated Category News Views 78

Navigating Investment Strategies in Changing Times As the investment environment shifts, many investors are evaluating where to place their money to achieve the best returns. With tech stocks, particularly those dubbed the Magnificent Seven, facing ups and downs, an increasing number of investors are exploring traditional investment options that are known for their...

Continue Reading